Corpay Operating Cash Flow decreased by 107.0% to -$56.62M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.6%, from -$74.15M to -$56.62M. Over 3 years (FY 2021 to FY 2024), Operating Cash Flow shows an upward trend with a 17.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $278.59M | $243.10M | $597.52M | -$112.25M | $154.11M | $396.75M | $316.19M | $877.67M | $221.30M | $285.67M | $716.50M | $350.18M | $540.92M | $400.79M | $648.67M | -$74.15M | $1.14B | $812.74M | -$56.62M |
| QoQ Change | — | -12.7% | +145.8% | -118.8% | +237.3% | +157.5% | -20.3% | +177.6% | -74.8% | +29.1% | +150.8% | -51.1% | +54.5% | -25.9% | +61.8% | -111.4% | >999% | -28.7% | -107.0% |
| YoY Change | — | — | — | — | -44.7% | +63.2% | -47.1% | +881.9% | +43.6% | -28.0% | +126.6% | -60.1% | +144.4% | +40.3% | -9.5% | -121.2% | +110.8% | +25.3% | +23.6% |